1. Beers M H. ed. Merck manual. Millennium edition. Merck, Sharpe and Dohme: Rahwey, New Jersey, USA 1999.
2. Winder C. ed. Proceedings of the BALPA Air Safety and Cabin Air Quality International Aero Industry Conference; 20–21 April 2005, London, Sydney, Australia: BALPA and the School of Safety Science, University of New South Wales 2005.
3. Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet 1999. 354936–939.939. [PubMed] 4. McLaren N. The biopsychosocial model and scientific fraud. Aust N Z J Psychiatry 2001. 35724–730.730. [PubMed]
5. McLaren N. The biopsychosocial model in psychiatry. The future of psychiatry: a critical analysis of the scientific status psychiatry. 2005. http://www.futurepsychiatry.com (accessed 10 Aug 2006)
6. McLaren N. When does ignorance become fraud? The future of psychiatry: a critical analysis of the scientific status of psychiatry. 2003. http://www.futurepsychiatry.com (accessed 10 Aug 2006)
7. Dalen P. Somatic medicine abuses psychiatry and neglects causal research. http:art‐bincom/art/dalen_en.html. (Accessed 4 Jan 2003)
8. Anon A new clinical entity [leading article]? Br Med J 1956. 26789–790.790.
9. Lyle W H, Chamberlain R N. eds. Epidemic neuromyasthenia 1934–1977. Postgrad Med J 1978. 54637, 707–637, 774.637, 774.
10. McEvedy C P, Beard A W. Royal Free epidemic of 1955. A reconsideration. Br Med J 1970. 17–11.11. [PMC free article] [PubMed]
11. Hyde B M. A new and simple definition of myalgic encephalomyelitis and a new and simple definition of chronic fatigue syndrome & a brief history of myalgic encephalomyelitis & an irreverent history of chronic fatigue syndrome. Presentation to the Invest in ME Conference, 12 May, 2006. http://www.investinme.org/Documents/PDFdocuments/Byron%20Hyde%20Little%Red%20Book%20for%2.www.investinme.org.pdf (Accessed 12 April 2007)
12. Sykes R, Campion P. Preliminary report: chronic fatigue syndrome/ME: trusting patients' perceptions of a multi‐dimensional physical illness. A collaborative report from Westcare .
13. Komaroff A. http://www.cfidsreport.com/Articles/NIH/NIH_CFS_4.htm (accessed April 2007) Quoted in “Energising biomedical research in ME/CFS”, a lecture by Dr Vance Spence, Chairman of Mar MERGE. http://www.meresearch.org.uk (accessed 10 Aug 2006)
14. Debate on “Does the government accept the WHO definition of myalgic encephalomyelitis?” Countess of 22 March Jan 2004. http://listserv.nodak.edu/scripts/wa.exe?A2=ind0401d&L=co‐cure&F=&S=&P=1313 (accessed 10 Aug 2006)
15. Hooper M., Members of the ME Community The mental health movement: persecution of patients? http://www.satori‐5.co.uk/word_articles/me_cfs/prof_hooper_3.html (accessed 10 Aug 2006)
16. ME Association Perspectives. ME Association: Buckingham, UK 1999.
17. The Countess of Mar How the law is being abused to force the treatment on children [opinion]. The Daily Telegraph 11 July 2001.
18. Royal College of Pediatrics and Child Health Evidence‐based guidelines for the management of CFS/ME in children and young people, 2004. Available at http://www.ayme.org.uk/article.php?sid=10&id=137 (accessed 12 April 2007)
19. 25% Group. March 2004 severe ME analysis report. http://www.25megroup.org/Group%20Leaflets/Group%20Leaflets.htm (accessed 1 April 2007)
20. Crowhurst G. 25% Group September 2005 Severly affected and graded excreise http://www.25megroup.org/Group%20Leaflets/Group%20Leaflets.htm (accessed 1 April 2007)
21. 25% Group. End the PACE/FINE trials. http://www.25megroup.org/, news .
22. Wessely S, Butler S, Chalder T. et al In: Cox R, Edwards F, Palmer K, eds. Fitness for work; the medical aspects. 3rd edn. Oxford: Oxford University Press, 2000.
23. Wilhelmsen I. Biological sensitization and psychological amplification: gateway to subjective health complaints and somatoform disorders. Psychoneuroendocrinology 2005. 30990–995.995. [PubMed] 24. Lloyd A R. To exercise or not to exercise in chronic fatigue syndrome? No longer a question. Med J Aust 2004. 181437–438.438. [PubMed] 25. Moss‐Morris R, Sharon C, Tobin R. et al A randomised controlled graded exercise trial for chronic fatigue syndrome: outcomes and mechanisms of change. J Health Psychol 2005. 10245–259.259. [PubMed] 26. Scroop G C, Burnett R B. To exercise or not to exercise in chronic fatigue syndrome – a response. Med J Aust 2004. 181578–580.580. [PubMed]
27. Mommersteeg P M C, Heijen C J, Verbraak M J P M. et al Clinical burnout is not reflected in the cortisol awakening response, day‐curve, or response to low‐dose dexamethasone test. Psychoneurendocrinology 2005. 31216–228.228.
28. Jason L A, Corradi K, Torres‐Harding S. et al Chronic fatigue syndrome: the need for subtypes. Neuropsychology 2005. 1529–58.58.
29. Kennedy G, Abbot N C, Spence V. et al The specificity of the CDC‐1994 criteria for chronic fatigue syndrome: comparison of health status in three groups of patients who fulfill the criteria. Ann Epidemiol 2004. 1495–100.100. [PubMed]
30. Carruthers B, Jain A, De Meirleir K. et al Canadian Clinical Working Group: case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndrome 2003. 117–115.115.
31. Carruthers B M, van de Sande M I. Myalgic encephalomyelitis/chronic fatigue syndrome: a clinical case definition and guidelines for medical practitioners (an overview of the Canadian Consensus Document). Carruthers and van de Sande Calgoy: 2005.
32. Chia J K S. The role of enteroviruses in chronic fatigue syndrome – a review. J Clin Pathol 2005. 581126–1132.1132. [PMC free article] [PubMed]
33. Hyde B M, Goldstein J, Levine P. The clinical and scientific basis of myalgic encephalomyelitis/chronic fatigue syndrome. Ottawa: Nightingale Research Foundation, 1992.
34. Richardson J. Enteroviral and toxin mediated myalgic encephalomyelitis/chronic fatigue syndrome and other organ pathologies. Binghampton, New York: Haworth Medical Press, 2001.
35. Robotham J. Brain link to fatigue syndrome. The Sydney Morning Herald, 4 May 2002. http://www.smh.com.au/articles/2002/05/03/1019441434909.html (accessed 10 Aug 2006)
36. Puri B K, Counsell S J, Zaman R. et al Relative increase in choline in the occipital cortex in chronic fatigue syndrome. Acta Psychiatr Scand 2002. 106224–226.226. [PubMed]
37. Chaudhuri A, Condon B R, Gow J W. et al Proton magnetic resonance spectroscopy of basal ganglia in chronic fatigue syndrome. Brain Imaging Neuroreport 2003. 14225–228.228.
38. Chaudhuri A, Behan P O. In vivo magnetic resonance spectroscopy in chronic fatigue syndrome. Prostaglandins Leukot Essent Fat Acids 2004. 71181–183.183.
39. Richardson J. Four cases of pesticide poisoning presenting as “ME”, treated with a choline ascorbic acid mixture. J Chronic Fatigue 2000. 611–21.21.
40. Rowat S C. Environ Health Perspect. 1998;106 (Suppl 1):S85–109.
41. Reetoo K N, Osman S A, Illavia S J. et al Quantitative analysis of viral RNA kinetics in coxsackievirus B3–induced murine myocarditis: biphasic pattern of clearance following acute infection with persistence of residual viral RNA throughout and beyond the inflammatory phase of disease. J Gen Virol 2000. 812755–2762.2762. [PubMed] 42. Lane R J M, Soteriou B A, Zhang H. et al Enterovirus related metabolic myopathy: a postviral fatigue syndrome. J Neurol Neurosurg Psychiatry 2003. 741382–1386.1386. [PMC free article] [PubMed] 43. Peckerman A, Lamanca J J, Dahl K A. et al Abnormal impedance cardiography predicts symptom severity in chronic fatigue syndrome of disease. Am J Med Sci 2003. 32655–60.60. [PubMed]
44. Myhill S. What is chronic fatigue syndrome? August 2005. http://www.drmyhill.co.uk .
45. Spence V A, Stewart J. Standing up for ME. Biologist 2004. 5165–70.70.
46. Kennedy G, Spence V A, Underwood C. et al Increased neutrophil apoptosis in chronic fatigue syndrome. J Clin Pathol 2004. 57891–893.893. [PMC free article] [PubMed] 47. Kennedy G, Spence V A, McLaren M. et al Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic Biol Med 2005. 39584–589.589. [PubMed]
48. Spence V A, Khan F, Kennedy G. et al Inflammation and arterial stiffness in patients with Chronic Fatigue Syndrome. 8th International IACFS Conference on Chronic Fatigue Syndrome, Fibromyalgia and other related illnesses, Fort Lauderdale, Floride, USA, January, 2007 .
49. Spence V A. Advances in the biomedical investigation of ME Research Updates, May 2004. http://investinme.org/Documents/PDFdocuments/Advances%20in%20the%20Biomedical%20Investigation%20of%20ME.pdf .
50. Sophia, ME The story of Sophia Mirza document provided at the Invest in ME Conference, 12 May 2006, London. DVDs of the presentations on can be obtained from htpp://www.investinme.org .
51. McArdle F, Pattwell D M, Vasilaki A. et al Intracellular generation of reactive oxygen species by contracting skeletal muscle cells. Free Radic Biol Med 2005. 39651–657.657. [PubMed]
52. Chronic fatigue syndrome: a biological approach In: Englebienne P, De Meirleir K, eds. Boca Raton, Florida: CRC Press, 2002.
53. Vojdani A, Lapp C W. Interferon‐induced proteins are elevated in blood samples of patients with chemically/virally induced chronic fatigue syndrome. Immunopharmacol Immunotoxicol 1999. 21175–202.202. [PubMed]
54. Patarca‐Montero R, Mark T, Fletcher M A. et al In: De Meirleir K, Patarca‐Montero R, eds. Immunology of chronic fatigue syndrome in chronic fatigue syndrome critical reviews and clinical advances. London: Haworth Medical Press, 2000.
55. Patarca‐Montero R. Chronic fatigue syndrome, genes, and infection: the eta‐1/Op paradigm. New York: Haworth Medical Press, 2003.
56. Kaushik N, Fear D, Richards S C M. et al Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. J Clin Pathol 2005. 58826–832.832. [PMC free article] [PubMed]
57. Kerr J R, Binns J H. Presentation to the Invest in ME Conference, London, 12 May 2006. DVDs of the presentations on can be obtained from http://www.investinme.org .
58. Ramsay A M. Myalgic Encephalitis and Post Viral Fatigue States. 2nd edn. London: Gower Publishing, 1988.
59. Dowsett E G, Colby J. Long term sickness due to ME/CFS in UK schools. J Chronic Fatigue Syndrome 1997. 329–42.42.
60. Scientific progress in understanding Gulf War veterans' illnesses: report and recommendations of the Research Advisory Committee on Gulf War Veterans' Illnesses, RACGWI, November 2004. http://www1.va.gov/rac‐gwvi/docs/ReportandRecommendations_2004.pdf .
61. Walker M J. Skewed: psychiatric hegemony and the manufacture of mental illness. London: Slingshot Publications, 2003.